These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 11870504)

  • 1. Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer.
    Yang CH; Tsai CM; Wang LS; Lee YC; Chang CJ; Lui LT; Yen SH; Hsu C; Cheng AL; Liu MY; Chiang SC; Chen YM; Luh KT; Huang MH; Yang PC; Perng RP
    Br J Cancer; 2002 Jan; 86(2):190-5. PubMed ID: 11870504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M; Kovac V; Smrdel U; Strojan P
    J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
    Lee DH; Han JY; Cho KH; Pyo HR; Kim HY; Yoon SJ; Lee JS
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1037-44. PubMed ID: 16024178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).
    Schallier D; Neyns B; Fontaine C; Steene JV; De Mey J; Meysman M; De Grève J
    Lung Cancer; 2007 May; 56(2):247-54. PubMed ID: 17337086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).
    Van Zandwijk N; Smit EF; Kramer GW; Schramel F; Gans S; Festen J; Termeer A; Schlosser NJ; Debruyne C; Curran D; Giaccone G
    J Clin Oncol; 2000 Jul; 18(14):2658-64. PubMed ID: 10894864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine combined with cisplatin as neoadjuvant chemotherapy in stage IB-IIIA non-small cell lung cancer.
    Davidov MI; Polotzky BE; Marenich AF; Orlov SV; Lazarev AF; Skryabina LS; Pavlushkov EV; Semenchenya VA; Brichkova OY; Karaseva VV
    Anticancer Drugs; 2011 Jul; 22(6):569-75. PubMed ID: 21487288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin and gemcitabine induction chemotherapy followed by concurrent chemoradiotherapy or surgery for locally advanced non-small cell lung cancer.
    Byrne MJ; Phillips M; Powell A; Cameron F; Joseph D; Spry N; Dewar J; Van Hazel G; Buck M; Lund H; De Melker Y; Newman M
    Intern Med J; 2005 Jun; 35(6):336-42. PubMed ID: 15892762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Remission rate of mediastinal lymph nodes after multimodal therapy of lung cancer--is it a prognostic factor?].
    Granetzny A; Striehn E; Bosse U; Wagner W; Koch O; Vogt U; Froeschle P; Klinke F
    Zentralbl Chir; 2003 Aug; 128(8):640-4. PubMed ID: 12931258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis.
    Santo A; Pedersini R; Pasini F; Terzi A; Pari F; Cartei G; Sibau A; Molino A; Maiorino A; Panza N; Oletti MV; Maluta S; Calabrò F; Cetto GL
    Lung Cancer; 2001 Dec; 34 Suppl 4():S15-20. PubMed ID: 11742697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.
    Vokes EE; Herndon JE; Crawford J; Leopold KA; Perry MC; Miller AA; Green MR
    J Clin Oncol; 2002 Oct; 20(20):4191-8. PubMed ID: 12377962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: a multicentre study of galician-lung-cancer-group.
    León L; Cueva-Banuelos JF; Huidobro G; Fírvida JL; Amenedo M; Lázaro M; Romero C; Estévez SV; Barón FJ; Grande C; García Mata J; González A; Castellanos J; Gómez A; Caeiro M; Rodríguez MR; Casal J;
    Lung Cancer; 2003 May; 40(2):215-20. PubMed ID: 12711124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemzar platinum combinations: phase III trials in non-small cell lung cancer.
    Crinò L; Calandri C
    Lung Cancer; 2002 Nov; 38 Suppl 2():S9-12. PubMed ID: 12431823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose escalation of gemcitabine concomitant with radiation and cisplatin for nonsmall cell lung cancer: a phase 1-2 study.
    Momm F; Kaden M; Tannock I; Schumacher M; Hasse J; Henke M
    Cancer; 2010 Oct; 116(20):4833-9. PubMed ID: 20589760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine (Gemzar)-based induction chemotherapy in non-small-cell lung cancer.
    Scagliotti GV; Novello S
    Lung Cancer; 2002 Nov; 38 Suppl 2():S13-9. PubMed ID: 12431824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2
    Zhong WZ; Chen KN; Chen C; Gu CD; Wang J; Yang XN; Mao WM; Wang Q; Qiao GB; Cheng Y; Xu L; Wang CL; Chen MW; Kang X; Yan W; Yan HH; Liao RQ; Yang JJ; Zhang XC; Zhou Q; Wu YL
    J Clin Oncol; 2019 Sep; 37(25):2235-2245. PubMed ID: 31194613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating concurrent navelbine and cisplatin to hyperfractionated radiotherapy in locally advanced non-small cell lung cancer patients treated with induction and consolidation chemotherapy: feasibility and activity results.
    Reguart N; Viñolas N; Casas F; Gimferrer JM; Agustí C; Molina R; Martin-Richard M; Sanchez-Reyes A; Gascón P
    Lung Cancer; 2004 Jul; 45(1):67-75. PubMed ID: 15196736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer.
    Abratt RP; Bezwoda WR; Goedhals L; Hacking DJ
    J Clin Oncol; 1997 Feb; 15(2):744-9. PubMed ID: 9053500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final overall results of a study with a novel triplet induction chemotherapy regimen (PACCAGE) followed by consolidation radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC).
    Schallier D; Bral S; Ilsen B; Neyns B; Fontaine C; Decoster L; De Mey J; Meysman M; De Grève J
    J Thorac Oncol; 2009 Jun; 4(6):728-35. PubMed ID: 19404217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.
    Sandler AB; Nemunaitis J; Denham C; von Pawel J; Cormier Y; Gatzemeier U; Mattson K; Manegold C; Palmer MC; Gregor A; Nguyen B; Niyikiza C; Einhorn LH
    J Clin Oncol; 2000 Jan; 18(1):122-30. PubMed ID: 10623702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.